Zoetis Adds to its Portfolio

Zoetis has acquired the marketing rights for Loncor 300 from Elanco. This broad-spectrum antibiotic is used to treat respiratory disease and foot rot in cattle. Zoetis will begin marketing Loncor 300 this quarter and new packaging will come to market later this year.